Gina Fridley
パートナー,
Gina
専門分野
Gina Fridley is a member of our Healthcare & Life Sciences practice.
She works with both corporate life sciences clients and financial investors, often focused on scientifically technical topics, growth and transformation, and recently, how AI can drive innovation and productivity growth.
Recent projects include: assisting a diagnostics company in establishing their Covid testing business, supporting a life sciences company in launching their genAI transformation, and leading multiple due diligences for financial investors evaluating acquisitions of innovative life sciences software and tools.
Gina finds energy bringing together her technical understanding of life sciences with the authentic personal relationships that are built working closely with clients navigating times of immense change.
Gina earned her PhD in Bioengineering from the University of Washington and a BS in Biological Engineering from the Massachusetts Institute of Technology (MIT).
Recent Insights
- “How Life Sciences Leaders Are Widening the AI Capability Gap,” スナップチャート, 2026年1月26日
- “From Silos to Pods: Scaling AI in Life Sciences,” スナップチャート, 2026年1月12日
- “In Life Sciences, AI Moves Fast, but Only When Leaders Do,” スナップチャート, 2026年1月5日
- “The Pandemic Forced Agile Innovation in Healthcare. Now Make It Stick.,” 論説, 2021年10月15日